Edwards Sells Critical Care Unit to BD for $4.2 Billion: What Does This Mean for the Healthcare Sector?
Monday, 3 June 2024, 14:41
Edwards Sells Critical Care Unit to BD for $4.2 Billion
In a strategic move, Edwards Lifesciences Corporation has sold its Critical Care business unit to Becton, Dickinson and Company (BD) for a significant $4.2 billion.
This acquisition is poised to reshape the landscape of the healthcare industry, with potential implications for both companies and stakeholders.
The deal marks a key milestone for Edwards as it streamlines its focus on its core business areas, while BD expands its portfolio in critical care solutions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.